Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 14: Inject 20 units (0.2 mL) one time per week Weeks 58: Inject 40 units (0.4 mL) one time per week Weeks 912: Inject 70 units (0.7 mL) one time per week Weeks 1316: Inject 90 units (0.9 mL) one time per week Weeks 1720: Inject 120 units (1.2 mL) one time per week Week 21+: Inject 140 units (1.4 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
Quick Answer: BPC-157 is a synthetic peptide derived from a protein naturally found in the stomach
It does not constitute medical or cosmetic advice
Let your provider know if you: Take any other prescription medications or over-the-counter medicines Use herbal supplements or weight-loss products Have a history of kidney disease , pancreatitis , or heart problems Have experienced adverse reactions to other injectable drugs Are currently taking Wegovy, Mounjaro, or Rybelsus Achieve Weight Loss at a Top-Rated Medspa in Volusia County If you live within Volusia County and want to loss weights, contact the best in the area, Total Anti-Aging & Wellness
Nat Astron (2026)
View Canadian testing status & COAs Suggested Research Applications GHK-Cu is frequently explored in laboratory research models involving: Extracellular matrix behavior , collagen-related signaling, and structural support pathways Peptidemetal interactions , copper binding dynamics, and metallopeptide stability Tissue response studies , including models assessing environmental stress and cellular resilience Regeneration-associated pathways examined in controlled in vitro settings Cellular communication and signaling mechanisms connected to peptide-regulated processes (For laboratory research use only
